Population pharmacokinetic modelling of irosustat in postmenopausal women with oestrogen-receptor positive breast cancer incorporating non-linear red blood cell uptake
Latest Information Update: 29 Jan 2016
Price :
$35 *
At a glance
- Drugs Irosustat (Primary)
- Indications Breast cancer
- Focus Pharmacokinetics; Therapeutic Use
- 29 Jan 2016 New trial record